BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12869218)

  • 1. Human nerve growth factor receptor and cytosine deaminase fusion genes.
    Lewis VA; Basso L; Blake N; Salo J; Lund TC; McIvor RS; Orchard PJ
    Hum Gene Ther; 2003 Jul; 14(10):1009-16. PubMed ID: 12869218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of the uracil phosphoribosyltransferase gene with a chimeric human nerve growth factor receptor/cytosine deaminase fusion gene, using a single retroviral vector, augments cytotoxicity of transduced human T cells exposed to 5-fluorocytosine.
    O'Brien TA; Tuong DT; Basso LM; McIvor RS; Orchard PJ
    Hum Gene Ther; 2006 May; 17(5):518-30. PubMed ID: 16716109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and testing of gene therapy retroviral vector expressing bacterial cytosine deaminase gene.
    Hlavatý J; Hlubinová K; Altaner C
    Neoplasma; 1999; 46(5):267-76. PubMed ID: 10665841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor.
    Mullen CA; Coale MM; Lowe R; Blaese RM
    Cancer Res; 1994 Mar; 54(6):1503-6. PubMed ID: 8137255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme/prodrug therapy for head and neck cancer using a catalytically superior cytosine deaminase.
    Hamstra DA; Rice DJ; Fahmy S; Ross BD; Rehemtulla A
    Hum Gene Ther; 1999 Aug; 10(12):1993-2003. PubMed ID: 10466633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme/prodrug gene therapy for human colon cancer cells using adenovirus-mediated transfer of the Escherichia coli cytosine deaminase gene driven by a CAG promoter associated with 5-fluorocytosine administration.
    Koyama F; Sawada H; Fujii H; Hirao T; Ueno M; Hamada H; Nakano H
    J Exp Clin Cancer Res; 2000 Mar; 19(1):75-80. PubMed ID: 10840940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined suicide gene therapy for human colon cancer cells using adenovirus-mediated transfer of escherichia coli cytosine deaminase gene and Escherichia coli uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Koyama F; Sawada H; Hirao T; Fujii H; Hamada H; Nakano H
    Cancer Gene Ther; 2000 Jul; 7(7):1015-22. PubMed ID: 10917204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteoclasts direct bystander killing of cancer cells in vitro.
    Ramnaraine M; Pan W; Clohisy DR
    Bone; 2006 Jan; 38(1):4-12. PubMed ID: 16139579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transduction of thymidine phosphorylase cDNA facilitates efficacy of cytosine deaminase/5-FC gene therapy for malignant brain tumor.
    Manome Y; Watanabe M; Abe T; Tomita M; Watanabe S; Yokokawa Y; Takahashi Y; Ishii K; Kimura A; Murakami M; Nagata M; Shibata T; Nakamura M; Tanigawa N; Ohno T
    Anticancer Res; 2001; 21(4A):2265-72. PubMed ID: 11724281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular chemotherapy combined with radiation therapy enhances killing of cholangiocarcinoma cells in vitro and in vivo.
    Pederson LC; Buchsbaum DJ; Vickers SM; Kancharla SR; Mayo MS; Curiel DT; Stackhouse MA
    Cancer Res; 1997 Oct; 57(19):4325-32. PubMed ID: 9331094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cancer gene therapy by adenovirus-mediated transfer of a bifunctional yeast cytosine deaminase/uracil phosphoribosyltransferase fusion gene.
    Erbs P; Regulier E; Kintz J; Leroy P; Poitevin Y; Exinger F; Jund R; Mehtali M
    Cancer Res; 2000 Jul; 60(14):3813-22. PubMed ID: 10919655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experimental treatment of brain tumor cells using CD suicide gene].
    Xu LF; Ge K; Zheng ZC; Sun LY; Liu XY
    Shi Yan Sheng Wu Xue Bao; 1996 Dec; 29(4):385-93. PubMed ID: 9772683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosine deaminase/5-fluorocytosine-based vaccination against liver tumors: evidence of distant bystander effect.
    Pierrefite-Carle V; Baqué P; Gavelli A; Mala M; Chazal M; Gugenheim J; Bourgeon A; Milano G; Staccini P; Rossi B
    J Natl Cancer Inst; 1999 Dec; 91(23):2014-9. PubMed ID: 10580026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiosensitization by 5-fluorocytosine of human colorectal carcinoma cells in culture transduced with cytosine deaminase gene.
    Khil MS; Kim JH; Mullen CA; Kim SH; Freytag SO
    Clin Cancer Res; 1996 Jan; 2(1):53-7. PubMed ID: 9816090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytosine deaminase gene as a potential tool for the genetic therapy of colorectal cancer.
    Rowley S; Lindauer M; Gebert JF; Haberkorn U; Oberdorfer F; Moebius U; Herfarth C; Schackert HK
    J Surg Oncol; 1996 Jan; 61(1):42-8. PubMed ID: 8544459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
    Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
    Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Provision of positive and negative selections in retroviral vectors containing the cytosine deaminase gene.
    Shiau AL; Yang HM; Wu P; Wu CL
    Gene Ther; 1998 Nov; 5(11):1571-4. PubMed ID: 9930312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental gene therapy for brain tumors using adenovirus-mediated transfer of cytosine deaminase gene and uracil phosphoribosyltransferase gene with 5-fluorocytosine.
    Adachi Y; Tamiya T; Ichikawa T; Terada K; Ono Y; Matsumoto K; Furuta T; Hamada H; Ohmoto T
    Hum Gene Ther; 2000 Jan; 11(1):77-89. PubMed ID: 10646641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study on human pancreatic carcinoma treated by cytosine deaminase gene therapy].
    Zhang S; Yuan S
    Zhonghua Yi Xue Za Zhi; 2000 Apr; 80(4):249-51. PubMed ID: 11798763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus mediated cytosine deaminase gene transduction and 5-fluorocytosine therapy sensitizes mouse prostate cancer cells to irradiation.
    Anello R; Cohen S; Atkinson G; Hall SJ
    J Urol; 2000 Dec; 164(6):2173-7. PubMed ID: 11061950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.